查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1916903

靜脈輸液袋市場按溶液配方、溶液類型、給藥方法、包裝材料、最終用戶、應用和分銷管道分類－2026-2032年全球預測

Intravenous Fluid Bags Market by Fluid Composition, Fluid Type, Administration Mode, Packaging Material, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，靜脈輸液袋市場價值將達到 13.4 億美元，到 2026 年將成長至 14.2 億美元，到 2032 年將達到 21 億美元，年複合成長率為 6.68%。

關鍵市場統計數據
基準年 2025 13.4億美元
預計年份：2026年 14.2億美元
預測年份 2032 21億美元
複合年成長率 (%) 6.68%

全面介紹輸液袋，概述其臨床適應症、製造材料、監管壓力、供應鏈趨勢以及在各種環境下的使用趨勢

靜脈輸液袋仍然是現代臨床照護的重要組成部分，可在各種情況下用於補充液體、復甦、給藥和營養支持。臨床醫生期望這些產品性能穩定可靠，而供應鏈和採購團隊則需要清楚了解材料成分、包裝和通路，以確保供應不間斷。在此背景下，製造商需要在臨床療效、不斷變化的監管要求和環境因素之間尋求平衡，從而推動材料選擇和生產方法的變革。

對重塑靜脈輸液袋設計、採購、臨床通訊協定、環境優先事項和數位化庫存管理實踐的轉型轉變進行策略評估

輸液袋領域正經歷多項變革，這些變革影響著輸液袋的設計、採購和臨床應用。首先，日益嚴格的監管審查和品質要求促使供應商改進聚合物的選擇和滅菌工藝，同時提高批次間的可追溯性和序列化程度。這些措施在急診和分散式醫療環境中都變得愈發重要，因為在這些環境中，產品性能的一致性至關重要。

對 2025 年美國關稅對供應鏈韌性、成本結構、採購決策和監管合規壓力的累積影響進行重點分析。

2025年美國關稅政策對輸液袋生態系內的成本結構、籌資策略和供應商關係產生了連鎖反應。進口聚合物、組件和成品的關稅相關課稅增加了買家的進口成本，迫使採購部門重新評估供應商所在地，並在條件允許的情況下加快近岸外包和供應商多元化策略。為此，一些製造商正在重新分配生產，優先發展國內或區域生產線，以降低進口關稅和地緣政治風險的影響。

可操作的細分分析揭示了輸液製劑、類型、給藥方法和包裝材料的產品創新、臨床應用模式、分銷管道趨勢和最終用戶優先事項

市場區隔反映了靜脈輸液袋市場中不同的產品、終端用戶和包裝動態，這些動態驅動著臨床選擇和商業策略，每種情況都需要量身定做的方法。根據液體成分，相關人員評估膠體溶液和晶體溶液。膠體溶液進一步分為白蛋白溶液、聚葡萄糖、明膠溶液和澱粉溶液，而晶體溶液則分為平衡溶液和生理食鹽水。每種溶液都具有特定的血液動力學和電解質管理特性，從而影響醫院的處方集和手術全期通訊協定。根據液體類型，市場涵蓋葡萄糖溶液、乳酸林格氏液和氯化鈉溶液，這些溶液的選擇取決於臨床適應症，例如滲透壓管理、電解質補充和維持治療。

區域洞察提供了對美洲、歐洲、中東、非洲和亞太地區的需求促進因素、採購政策、製造地和治療模式的全面分析。

區域趨勢正在以不同的方式影響著各主要地區靜脈輸液袋的採購、監管和生產策略。在美洲，採購流程較為複雜，私立醫院網路和大規模綜合醫療系統對供應商的選擇起著重要作用。能夠展現品管系統、靈活物流和永續性承諾的供應商往往更容易被選中。美洲地區同時存在公共採購和私人契約，這就需要靈活的商業模式。

提供領先的輸液袋製造商和供應商的競爭情報，概述其企業策略、生產能力、夥伴關係模式、產品差異化和關鍵成長因素。

輸液袋領域的主要企業正透過產品研發、產能擴張和合作等多種策略來應對臨床和供應方面的挑戰。領先的製造商正加大對材料科學的投入，以拓展其非PVC產品線，從而在滿足輸液藥物穩定性要求的同時，降低對環境的影響。這些投資與產能策略相輔相成，重點在於法規遵循、製程檢驗，以及在貿易或原料供應中斷的情況下快速找到合適的替代聚合物供應商。

切實可行的、優先考慮的建議，旨在加強供應鏈，促進永續包裝的採用，最佳化臨床利用，並創建新的分銷和服務模式。

產業領導者應優先採取一系列具體行動，以增強靜脈輸液袋產品線的韌性，提升臨床療效，並促進永續性。首先，應實現製造地多元化，並投資於合格的二級供應商，以降低單一來源依賴的風險，並在貿易或原料供應出現波動時迅速調配生產。同時，應加快材料轉型計劃，評估非聚氯乙烯（PVC）聚合物的生命週期優勢，並嚴格檢驗臨床適用性和滅菌效果。

對調查方法、資料來源、檢驗過程、相關人員訪談以及用於確保對市場進行嚴謹理解的分析框架進行透明的描述。

本分析所依據的研究採用了混合方法，整合了與主要相關人員的對話、二手文獻綜述和定性檢驗，以確保研究結果的嚴謹性和平衡性。關鍵投入包括與臨床醫生、採購負責人、監管專家和供應鏈經理進行結構化訪談，以收集有關產品性能、採購挑戰和臨床偏好的實際見解。這些訪談，以及與製造商和經銷商的針對性對話，有助於了解生產能力、材料選擇和物流限制。

總結全文，為製造商、醫療保健系統、經銷商和政策制定者提供明確的策略啟示。明確近期和結構性行動的優先事項。

總之，輸液袋市場正處於轉折點，臨床需求、監管預期、永續性壓力和貿易趨勢的交匯正在重塑產品設計和供應策略。積極推動材料轉換、實現製造地多元化並加強經銷夥伴的相關人員，將更有利於確保臨床供應的連續性，同時滿足環境和監管要求。臨床應用模式和給藥偏好進一步凸顯了設備相容性和標籤清晰度在採購決策中的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依輸液成分分類的靜脈輸液袋市場

  • 膠體製劑
    • 白蛋白
    • 聚葡萄糖
    • 明膠
    • 澱粉
  • 晶體溶液
    • 平衡液體
    • 生理食鹽水

9. 依輸液類型分類的靜脈輸液袋市場

  • 葡萄糖溶液
  • 林格氏乳酸鹽溶液
  • 氯化鈉溶液

10. 依給藥方式分類的靜脈輸液袋市場

  • 重力輸液
  • 點滴幫浦
  • 注射式幫浦

第11章 依包裝材料分類的靜脈輸液袋市場

  • 不含聚氯乙烯
    • 乙烯-醋酸乙烯酯
    • 聚烯
  • PVC

第12章 依最終用戶分類的靜脈輸液袋市場

  • 門診手術中心
  • 診所
  • 居家醫療
  • 醫院
    • 私立醫院
    • 公立醫院

第13章 依應用分類的靜脈輸液袋市場

  • 緊急醫療護理
  • 預防醫學
  • 外科手術
  • 治療護理

14. 按通路分類的靜脈輸液袋市場

  • 直銷
  • 醫院藥房
  • 網路藥房
  • 零售藥房

15. 按地區分類的靜脈輸液袋市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 靜脈輸液袋市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

17. 各國靜脈輸液袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章美國靜脈輸液袋市場

第19章：中國靜脈輸液袋市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Grifols, SA
  • Hikma Pharmaceuticals PLC
  • ICU Medical, Inc.
  • Nipro Corporation
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Terumo Corporation
Product Code: MRR-AE420CB153E3

The Intravenous Fluid Bags Market was valued at USD 1.34 billion in 2025 and is projected to grow to USD 1.42 billion in 2026, with a CAGR of 6.68%, reaching USD 2.10 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.34 billion
Estimated Year [2026] USD 1.42 billion
Forecast Year [2032] USD 2.10 billion
CAGR (%) 6.68%

An integrated introduction to intravenous fluid bags that outlines clinical indications, manufacturing materials, regulatory pressures, supply chain dynamics, and cross-setting utilization trends

Intravenous fluid bags remain a foundational element of modern clinical care, enabling hydration, resuscitation, medication delivery and nutritional support across a diverse set of settings. Clinicians depend on predictable performance from these products, while supply chain and procurement teams require clarity on material composition, packaging formats and distribution pathways to ensure uninterrupted availability. Against this backdrop, manufacturers are balancing clinical efficacy with evolving regulatory expectations and environmental considerations, prompting shifts in material choices and manufacturing practices.

As clinical protocols evolve, the role of fluid selection-ranging from isotonic crystalloids to colloid solutions-intersects with rising attention to compatibility with infusion systems, biocompatibility of packaging materials and infection prevention standards. At the same time, health systems and ambulatory providers are re-evaluating inventory strategies to minimize waste and ensure rapid access during surges. This requires an integrated approach that connects product design, supplier networks and end-user workflows.

Consequently, stakeholders must reconcile clinical preferences with logistical constraints and sustainability objectives. The introduction outlines these converging pressures and frames the subsequent sections, which examine technological, regulatory and commercial dynamics that will shape how intravenous fluid bags are produced, procured and used in the near term and beyond.

A strategic assessment of transformative shifts reshaping intravenous fluid bag design, sourcing, clinical protocols, environmental priorities and digital-enabled inventory management practices

The landscape for intravenous fluid bags is undergoing several transformative shifts that affect design, sourcing and clinical deployment. First, regulatory scrutiny and quality expectations are prompting suppliers to refine polymer selection and sterilization processes while improving traceability and serialization across batches. These measures are increasingly important for both acute care environments and decentralized settings, where consistent product performance is essential.

Second, sustainability considerations are influencing material innovation and packaging strategies. Innovations such as reduced-PVC solutions and alternative polymers are being evaluated not only for their environmental benefits but also for compatibility with existing infusion devices and sterilization regimes. This parallel focus on clinical compatibility and lifecycle impact is reshaping procurement criteria and supplier conversations.

Third, digital enablement of inventory and procurement functions is accelerating adoption of connected supply chain practices. Providers are piloting inventory telemetry and electronic procurement integrations to reduce expiries and improve replenishment speed, thereby altering how manufacturers package and ship products. Finally, clinical practice evolution-driven by evidence on fluid choice, perioperative management and outpatient infusion programs-is changing demand patterns across settings. Taken together, these shifts require integrated responses from manufacturers, distributors and clinical leaders to optimize product portfolios and delivery models.

A focused analysis of the cumulative impacts of United States tariffs in 2025 on supply chain resilience, cost structures, sourcing decisions and regulatory compliance pressures

The imposition of tariffs in the United States in 2025 has had a cascading effect on cost structures, sourcing strategies and supplier relationships within the intravenous fluid bag ecosystem. Tariff-related duties on imported polymers, components and finished goods have increased landed costs for purchasers, prompting procurement teams to reassess supplier footprints and to accelerate nearshoring and supplier diversification strategies where feasible. In response, some manufacturers have revisited production allocation, prioritizing domestic or regional manufacturing lines to mitigate exposure to import duties and geopolitical risks.

Consequently, distributors and health systems have had to adapt contractual terms and inventory policies to absorb price volatility while maintaining clinical continuity. Many stakeholders have sought longer-term supply agreements and collaborative risk-sharing arrangements to stabilize access and support capital investments in domestic manufacturing capacity. At the same time, tariff pressure has elevated the importance of cost-to-serve analyses and lifecycle assessments when comparing alternative packaging materials, since higher import costs alter the relative economics of PVC versus non-PVC solutions and may accelerate migration toward locally produced options.

Regulatory compatibility and quality assurance remain non-negotiable, so any shift in sourcing must be accompanied by accelerated validation, supplier audits and clear change-management communications to clinical teams. Ultimately, the 2025 tariff changes have underscored the need for agility in sourcing, a premium on manufacturing flexibility and the strategic value of multi-sourced supply chains that can sustain patient care under shifting trade conditions.

Actionable segmentation insights revealing product innovation, clinical adoption patterns, channel behaviors and end-user priorities across fluid composition, types, administration and packaging materials

Segmentation drives both clinical choices and commercial strategy in the intravenous fluid bag market, reflecting distinct product, end-user and packaging dynamics that require tailored approaches. Based on fluid composition, stakeholders evaluate Colloids versus Crystalloids, with Colloids further differentiated by Albumin, Dextrans, Gelatins and Starches and Crystalloids separated into Balanced Solutions and Normal Saline, each offering particular hemodynamic and electrolyte management characteristics that influence hospital formularies and perioperative protocols. Based on fluid type, the market encompasses Dextrose Solution, Ringer's Lactate Solution and Sodium Chloride Solution, which are selected according to clinical indications such as osmolarity management, electrolyte replacement and maintenance therapy.

Based on end user, demand patterns differ markedly across Ambulatory Surgical Centers, Clinics, Home Care and Hospitals, with hospitals further distinguished into Private Hospitals and Public Hospitals, each segment presenting unique procurement cycles, contract structures and usage intensities. Based on administration mode, gravity infusion remains prevalent in low-acuity settings while Infusion Pumps and Syringe Pumps dominate controlled infusion scenarios, influencing compatibility and labeling requirements. Based on packaging material, products are classified as Non-PVC and PVC, with Non-PVC options including Ethylene Vinyl Acetate and Polyolefin; material choice affects shelf life, environmental footprint and device compatibility.

Based on application, use cases span Emergency Care, Preventive Care, Surgical Procedures and Therapeutic Care, which drive formulation preferences and packing volumes. Based on distribution channel, Direct Sales, Hospital Pharmacy, Online Pharmacy and Retail Pharmacy each present different margins, service expectations and regulatory touchpoints. These segmentation layers interact to create differentiated product lifecycles and commercialization pathways that manufacturers and providers must navigate deliberately.

Regional insights synthesizing demand drivers, procurement policies, manufacturing footprints and treatment patterns across the Americas, Europe Middle East & Africa and Asia-Pacific

Regional dynamics shape procurement, regulation and manufacturing strategies for intravenous fluid bags in distinct ways across major geographies. In the Americas, procurement sophistication is high and private hospital networks and large integrated delivery systems exert influence over supplier selection, often favoring suppliers who can demonstrate quality systems, responsive logistics and sustainability credentials. The Americas region also includes a combination of public procurement agendas and private contracting that requires flexible commercial models.

In Europe, Middle East & Africa, regulatory frameworks and reimbursement models vary widely; European regulatory rigor coexists with emerging-market needs in parts of the Middle East and Africa where distribution complexity and cold chain considerations can be pronounced. These differences necessitate adaptable packaging and labeling strategies, as well as tailored commercial approaches for public tenders and private purchasers. In Asia-Pacific, a mix of large public health systems, expanding private care delivery and robust manufacturing ecosystems influences both demand and supply. Asia-Pacific manufacturers have increasingly integrated into global supply chains, offering scale and cost efficiencies while local regulatory pathways are evolving to emphasize product safety and environmental considerations.

Understanding these regional nuances enables manufacturers and distributors to prioritize investments in localized manufacturing, regulatory dossiers and channel partnerships that align with regional procurement realities and clinical practice patterns.

Competitive intelligence summarizing company strategies, manufacturing capabilities, partnership models, product differentiation and growth levers among leading intravenous fluid bag manufacturers and suppliers

Key companies in the intravenous fluid bag sector are pursuing a mix of product development, capacity expansion and partnership strategies to address clinical and supply-side priorities. Leading manufacturers are investing in material science to expand non-PVC offerings that reduce environmental impact while ensuring compatibility with infusible drug stability requirements. These investments are coupled with production capacity strategies that emphasize regulatory compliance, process validation and the ability to qualify alternative polymer suppliers rapidly when trade or raw material disruptions occur.

At the same time, several firms are augmenting their value proposition through service-oriented offerings, such as integrated logistics, inventory management tools and clinical education programs that help downstream purchasers optimize utilization and reduce waste. Strategic alliances and targeted acquisitions are being used to acquire specialty formulations, regional distribution networks and infusion device compatibility expertise. Firms that combine robust quality management systems with flexible production footprints and an emphasis on sustainability reporting are better positioned to meet increasing procurement and regulatory expectations.

Competitive differentiation also stems from the ability to support complex commercial models-such as consignment, outcome-based contracting and bundled supply agreements-that align incentives across providers and suppliers. As stakeholders demand greater transparency on supply chain resilience and product provenance, companies that can demonstrate end-to-end control and rapid response capabilities will secure stronger commercial positions.

Practical and prioritized recommendations to strengthen supply chains, accelerate sustainable packaging adoption, optimize clinical utilization and unlock new distribution and service models

Industry leaders should prioritize a set of concrete actions to strengthen resilience, support clinical outcomes and advance sustainability across their intravenous fluid bag portfolios. First, invest in diversified manufacturing footprints and validated secondary suppliers to reduce single-source vulnerability and to enable rapid allocation of production in response to trade or raw material shocks. Simultaneously, accelerate material transition programs that evaluate non-PVC polymers for lifecycle benefits while rigorously validating clinical compatibility and sterilization outcomes.

Second, collaborate with major health system customers to implement inventory visibility tools and integrated replenishment models that reduce expiration-related waste and improve fill rates during demand surges. These collaborations can be extended to design pooled procurement or consignment arrangements that align incentives and distribute risk. Third, enhance product differentiation through labeling that facilitates safe use with common infusion devices and by offering clinician education modules that support evidence-based fluid selection and administration practices.

Finally, embed sustainability and regulatory readiness into product roadmaps by prioritizing polymers with lower environmental impact, improving packaging efficiency and maintaining proactive regulatory dossiers for rapid market entry. By sequencing these actions-starting with supply base resilience, followed by validated material transitions, integrated distribution solutions and clinician-focused support-leaders can deliver both near-term stability and medium-term competitive advantage.

A transparent description of research methodology, data sources, validation processes, stakeholder interviews and analytical frameworks used to ensure rigorous market understanding

The research underpinning this analysis applies a mixed-methods approach that integrates primary stakeholder engagement, secondary literature review and qualitative validation to ensure rigorous and balanced findings. Primary inputs included structured interviews with clinicians, procurement professionals, regulatory experts and supply chain managers to capture practical insights on product performance, sourcing challenges and clinical preferences. These interviews were complemented by targeted manufacturer and distributor dialogues to understand production capabilities, material choices and logistical constraints.

Secondary sources comprised peer-reviewed clinical literature, regulatory guidance documents and industry technical standards that informed interpretations of material compatibility, sterilization methods and administration device interoperability. Where possible, publicly available regulatory filings and device registries were reviewed to validate claims about manufacturing locations and quality systems. Analytical frameworks included value-chain mapping, risk assessment matrices and scenario analysis to highlight vulnerabilities and stress-test potential responses to trade or demand disruptions.

Validation workshops with domain experts were used to reconcile divergent perspectives and to refine recommendations. Throughout the research process, emphasis was placed on traceability of claims and clarity of assumptions, ensuring that conclusions are anchored in observable practices and stakeholder testimony rather than speculative projections.

Conclusive synthesis articulating strategic implications for manufacturers, health systems, distributors and policymakers with clear priorities for near-term and structural actions

In conclusion, the intravenous fluid bag environment is at an inflection point where clinical requirements, regulatory expectations, sustainability pressures and trade dynamics intersect to reshape product design and supply strategies. Stakeholders that proactively address material transitions, diversify manufacturing footprints and strengthen distribution partnerships will be better positioned to ensure uninterrupted clinical supply while responding to environmental and regulatory imperatives. Clinical adoption patterns and administration mode preferences further underscore the importance of device compatibility and labeling clarity as differentiators in procurement decisions.

Moreover, the tariff environment and regional procurement variations have amplified the value of supply chain transparency and flexible contractual arrangements. Providers and manufacturers alike must collaborate more closely on inventory models and clinical education to optimize utilization and reduce waste. Finally, companies that can marry robust quality systems with sustainability credentials and service-oriented commercial models will create defensible positions that address both payer and provider priorities.

This synthesis highlights clear priorities for near-term operational adjustments and medium-term strategic investments that together will shape competitive outcomes and clinical reliability across care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous Fluid Bags Market, by Fluid Composition

  • 8.1. Colloids
    • 8.1.1. Albumin
    • 8.1.2. Dextrans
    • 8.1.3. Gelatins
    • 8.1.4. Starches
  • 8.2. Crystalloids
    • 8.2.1. Balanced Solutions
    • 8.2.2. Normal Saline

9. Intravenous Fluid Bags Market, by Fluid Type

  • 9.1. Dextrose Solution
  • 9.2. Ringer's Lactate Solution
  • 9.3. Sodium Chloride Solution

10. Intravenous Fluid Bags Market, by Administration Mode

  • 10.1. Gravity Infusion
  • 10.2. Infusion Pump
  • 10.3. Syringe Pump

11. Intravenous Fluid Bags Market, by Packaging Material

  • 11.1. Non-PVC
    • 11.1.1. Ethylene Vinyl Acetate
    • 11.1.2. Polyolefin
  • 11.2. PVC

12. Intravenous Fluid Bags Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Home Care
  • 12.4. Hospitals
    • 12.4.1. Private Hospitals
    • 12.4.2. Public Hospitals

13. Intravenous Fluid Bags Market, by Application

  • 13.1. Emergency Care
  • 13.2. Preventive Care
  • 13.3. Surgical Procedures
  • 13.4. Therapeutic Care

14. Intravenous Fluid Bags Market, by Distribution Channel

  • 14.1. Direct Sales
  • 14.2. Hospital Pharmacy
  • 14.3. Online Pharmacy
  • 14.4. Retail Pharmacy

15. Intravenous Fluid Bags Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Intravenous Fluid Bags Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Intravenous Fluid Bags Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Intravenous Fluid Bags Market

19. China Intravenous Fluid Bags Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. B. Braun Melsungen AG
  • 20.6. Baxter International, Inc.
  • 20.7. Fresenius Kabi AG
  • 20.8. Grifols, S.A.
  • 20.9. Hikma Pharmaceuticals PLC
  • 20.10. ICU Medical, Inc.
  • 20.11. Nipro Corporation
  • 20.12. Otsuka Pharmaceutical Co., Ltd.
  • 20.13. Pfizer Inc.
  • 20.14. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS FLUID BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAVENOUS FLUID BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTRANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTRANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTRANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GELATINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GELATINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GELATINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY STARCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY STARCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY STARCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY BALANCED SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY BALANCED SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY BALANCED SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTROSE SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTROSE SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTROSE SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RINGER'S LACTATE SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RINGER'S LACTATE SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RINGER'S LACTATE SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SODIUM CHLORIDE SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SODIUM CHLORIDE SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SODIUM CHLORIDE SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GRAVITY INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GRAVITY INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GRAVITY INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY INFUSION PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY INFUSION PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SYRINGE PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SYRINGE PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SYRINGE PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY EMERGENCY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY EMERGENCY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY EMERGENCY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PREVENTIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PREVENTIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PREVENTIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY THERAPEUTIC CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY THERAPEUTIC CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY THERAPEUTIC CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 223. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 226. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 227. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 229. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 257. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 258. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 259. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 261. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 262. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 263. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 269. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 270. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 271. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 273. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 274. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 275. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 277. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)